Furthermore, vitamin D has demonstrated therapeutic effects in NAFLD mouse models, thereby inhibiting pyroptosis by suppressing NLRP3 inflammasome activation and reducing lipid accumulation. This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatotic liver disease.